Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.
about
Amyloid-beta Alzheimer targets - protein processing, lipid rafts, and amyloid-beta poresAstrocytes As the Main Players in Primary Degenerative Disorders of the Human Central Nervous SystemVasculoprotection as a Convergent, Multi-Targeted Mechanism of Anti-AD Therapeutics and InterventionsEarly Signs of Pathological Cognitive Aging in Mice Lacking High-Affinity Nicotinic Receptors.Dihydropyridine Derivatives Modulate Heat Shock Responses and have a Neuroprotective Effect in a Transgenic Mouse Model of Alzheimer's Disease.Role of Different Alpha-Synuclein Strains in Synucleinopathies, Similarities with other Neurodegenerative DiseasesReduction of RPT6/S8 (a Proteasome Component) and Proteasome Activity in the Cortex is Associated with Cognitive Impairment in Lewy Body DementiaA genetically immortalized human stem cell line: a promising new tool for Alzheimer's disease therapy.Does Schizophrenia in Offspring Increase the Risk of Developing Alzheimer's Dementia.The ongoing pursuit of neuroprotective therapies in Parkinson disease.Antagonistic pleiotropic effects of nitric oxide in the pathophysiology of Parkinson's disease.Current Treatment Options for Alzheimer's Disease and Parkinson's Disease Dementia.Ethical Considerations for Deep Brain Stimulation Trials in Patients with Early-Onset Alzheimer's Disease.The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.Oral inflammation and infection, and chronic medical diseases: implications for the elderly.Neuropeptide Treatment with Cerebrolysin Enhances the Survival of Grafted Neural Stem Cell in an α-Synuclein Transgenic Model of Parkinson's Disease.Pharmacotherapy of Alzheimer's disease: current and future trends.Suppression of Presymptomatic Oxidative Stress and Inflammation in Neurodegeneration by Grape-Derived Polyphenols
P2860
Q26738355-AC33225C-4D3F-47F8-85AE-F8C27BD1DBDBQ26766006-269AC1F6-D42E-4368-9155-32567E98BBBEQ26781557-5CE3B39D-9045-40B3-9C58-ADEC500A5B99Q27323221-4BE33F60-34AB-4EDC-BD0C-8E80C4B9C146Q27333755-FC9BCDA4-3823-462E-AF4F-2002827EA3DEQ28082714-4C79F611-526D-4E67-866B-E0A849B9A04AQ33708946-05507C32-D614-4C37-81CF-90528B043BD1Q36847399-C46AECCD-EEBF-4C0C-A562-6F3A144EA96CQ37293621-5F716B5D-B108-4353-8469-942A0D0C076FQ38275171-B88C4056-6EA4-4751-8543-6AA52672B0B1Q38476696-8A58CD4C-F346-4A1E-A013-4CB931141ECFQ38661735-D30731E8-0F72-4B97-9105-98AC9DEF8F7DQ38691710-7DA38D7E-0282-4945-B95B-8683223EAFF0Q38775856-92B684B0-3186-4DA9-87CA-9DE99A677F17Q38921866-F504C3A8-4256-4CE4-8869-9A96A36191D8Q41832273-74085A37-5C6D-4300-AA92-2871C1920275Q48678220-A4C0D134-6BDB-4BF8-923B-6540BAB817A5Q58697995-9C14EC1E-4414-4F95-9DD2-CA9B11E43F33
P2860
Latest treatment options for Alzheimer's disease, Parkinson's disease dementia and dementia with Lewy bodies.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Latest treatment options for A ...... and dementia with Lewy bodies.
@en
type
label
Latest treatment options for A ...... and dementia with Lewy bodies.
@en
prefLabel
Latest treatment options for A ...... and dementia with Lewy bodies.
@en
P2860
P1476
Latest treatment options for A ...... and dementia with Lewy bodies.
@en
P2093
Anne Corbett
Martin Broadstock
P2860
P304
P356
10.1517/14656566.2014.936848
P407
P577
2014-07-03T00:00:00Z